Publications

Malone DC, Dean R, Arjunji R, Jensen IS, Cyr PL, Miller B, Maru B, et al. 2019. Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients. J Mark Access Health Pol 7(1):1601484; doi: 10.1080/20016689.2019.

Beckett EM, Cyrs WD, Abelmann A, Monnot AD, Gaffney SH, Finley BL. 2019. Derivation of an occupational exposure limit for diacetyl using dose-response data from chronic animal inhalation exposure study. J Appl Toxicol 39(5):688–701; doi: 10.1002/jat.3757.

Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period. Inhal Toxicol 31(6):213–223; doi: 10.1080/08958378.2019.1645768. PMID: 31380702.

Heintz MM, Kumar R, Rutledge M, Baldwin WS. 2019. Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis. J Nutr Biochem 70(August):125–137; doi: 10.1016/j.jnutbio.2019.05.004. PMID: 31202118.

Zucker RM, Rogers JM. 2019. Confocal laser scanning microscopy of morphology and apoptosis in organogenesis-stage mouse embryos. Meth Mol Biol 1965:297–311; doi: 10.1007/978-1-4939-9182-2_20.

Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, et al. 2019. United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38(2):141–155; doi: 10.1080/15569527.2018.1540494. PMID: 30418044.

Rogers JM, Watanabe M. 2019. Editorial: Special issue on “Developmental effects of smoking, vaping, and cannabis use.” Birth Defects Res 111(17):1245–1247; doi: 10.1002/bdr2.1596.

Rogers JM. 2019. Smoking and pregnancy: Epigenetics and the developmental origins of the metabolic syndrome. Birth Defects Res 111(17):1259–1269; doi: 10.1002/bdr2.1550.

Thomas RS, Bahadori T, Buckley T, Cowden J, Deisenroth C, Dionisio K, Frithsen J,…, Patlewicz G, et al. 2019. The next generation of computational toxicology at the US Environmental Protection Agency. Toxicol Sci 169(2):317-332; doi: 10.1093/toxsci/kfz058. PMID: 30835285.

Seo JE, Tryndyak V, Wu Q, Dreval K, Pogribny I, Bryant M, Zhou T, Robison TW, et al. 2019. Quantitative comparison in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-content Comet Chip assay. Arch Toxicol 93(5):1433-1448; doi: 10.1007/s00204-019-02406-9.

Scott PK, Abramson MM, Bare JL, Barlow CA. 2019. Air dispersion modeling for historical community exposure reconstruction: An evaluation of the approach and its uncertainties. EM-Mag Environ Mgrs January.

Rager JE, Suh M, Chappell G, Thompson CM, Proctor DM. 2019. Review of transcriptomic responses to hexavalent chromium exposure in lung cells supports a role of epigenetic mediators in carcinogenesis. Toxicol Lett 305(May 1):40-50; doi: 10.1016/j.toxlet.2019.01.011. PMID: 30690063.

Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. 2019. Potential airborne asbestos exposure and risk associated with the historical use of cosmetic talcum powder products. Risk Anal 39(10):2272-2294; doi: 10.1111/risa.13312. PMID: 30980426.

Vincent MJ, Kozal SJ, Thompson WJ, Maier A, Dotson GS, Best EA, Mundt KA. 2019. Ethylene oxide: Cancer evidence integration and dose-response implications. Dose Response 17(4):1559325819888317; doi: 10.1177/1559325819888317. PMID:3185323510.

Prior H, Monticello T, Boulifard V, Brennan FR, Kimber I. 2019. Integration of consortia recommendations for justification of animal use within current and future drug development paradigms. Int J Toxicol 38(4):319-325; doi: 10.1177/1091581819852922.

Helman G, Shah I, Williams AJ, Edwards J, Dunne J, Patlewicz G. 2019. Generalized Read-Across (GenRA): A workflow implemented into the EPA CompTox Chemicals Dashboard. ALTEX 36(3):462-465; doi: 10.14573/altex.1811292. PMID: 30741315.

Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2019. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: A randomized controlled trial. Global Pediat Health 6:1–10; doi: 10.1177/2333794X19833995. PMID: 30906817.

Wheeler MW, Piegorsch WW, Bailer AJ. 2019. Quantal risk assessment database: A database for exploring patterns in quantal dose‐response data in risk assessment and its application to develop priors for Bayesian dose‐response analysis. Risk Anal 39(3):616-29; doi: 10.1111/risa.13218. PMCID: PMC6408269

Wheeler MW. 2019. Bayesian additive adaptive basis tensor product models for modeling high dimensional surfaces: An application to high-throughput toxicity testing. Biometrics 75(1):193-201; doi: 10.1111/biom.12942. PMCID: PMC6363906.

Jacobs NFB, Towle KM, Finley BL, Gaffney SH. 2019. An updated evaluation of potential health hazards associated with exposures to asbestos-containing drywall accessory products. Crit Rev Toxicol 49(5):430–444; doi: 10.1080/10408444.2019.1639612.